Treating OUD With Buprenorphine Improves Pregnancy Outcomes
Drug Topics
MAY 6, 2025
Among patients treated with buprenorphine, 25.4% experienced adverse pregnancy outcomes, compared to 30.8% in the untreated group.
Drug Topics
MAY 6, 2025
Among patients treated with buprenorphine, 25.4% experienced adverse pregnancy outcomes, compared to 30.8% in the untreated group.
STAT
MAY 6, 2025
Five years ago, U.S. pharmaceutical companies didn’t license any new drugs from China. By 2024, one-third of their new compounds were coming from Chinese biotechnology firms. Why are U.S. drugmakers sending their business to China? As in many other industries, it’s so much cheaper to synthesize new compounds inside Chinese biotechnology firms once a novel biological target has been discovered in American laboratories.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 6, 2025
The use of electronic prescribing can also bridge the gap in clinical history, which can help pharmacists be aware of adverse drug reactions and medication interactions.
PharmaVoice
MAY 6, 2025
Chief executives at the largest drugmakers in the world are confident tariffs and pricing measures won’t be a major problem. But they’re still poised for change.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 6, 2025
In this episode of the podcast, Shawn and Jesse discuss how every situation has a solution and the best way to find it.
STAT
MAY 6, 2025
WASHINGTON — Vinay Prasad, an academic and fierce critic of the medical mainstream, will be the next director of the Food and Drug Administration center that oversees the regulation of vaccines, gene therapies, and the blood supply. Prasad, previously an epidemiology professor at the University of California, San Francisco, has sharply criticized the FDA in the past, including the Center for Biologics Evaluation and Research, the unit he will now lead.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 6, 2025
In “ We’ve Got You Covered ,” Liran Einav and Amy Finkelstein describe America’s existing patchwork of health care payment arrangements as a “teardown.” I agree. I support downsizing the Department of Health and Human Services (HHS), eliminating many programs, rolling back regulations , and creating a new system modeled on Social Security that will be simpler, less administratively burdensome, more affordable, and more effective at improving Americans&#x
The Checkup by Singlecare
MAY 6, 2025
Zinc is an essential nutrient for many bodily processes, such as immune function and wound healing. Your body doesnt naturally produce it, so you must consume it in the foods you eat or take a supplement to avoid a zinc deficiency. Luckily, many foods you probably already eat are chock-full of zinc, including seafood, red meat, poultry, whole grains, and legumes.
STAT
MAY 6, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, there’s been a lot of discussion lately about how the U.S. can stay competitive in science, biomedical innovation, and drug development. We’ve got several pieces of news relevant to that issue today.
Pharmaceutical Technology
MAY 6, 2025
The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 6, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning, I’m back! It seems like there was a lot of news while I was away … drop me a line at theresa.gaffney@statnews.com to let me know the biggest stories I missed.
Pharmacy Times
MAY 6, 2025
Abigail Thomas, PharmD, and Lee A. Kral, PharmD, discuss the evolving role of psilocybin-assisted therapy in palliative care, highlighting current evidence, safety concerns, and how pharmacists can guide patient selection, manage drug interactions, and support education as the therapy moves closer to clinical use.
STAT
MAY 6, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Google’s chief health officer Karen DeSalvo announced she will retire this summer. DeSalvo, who likes to introduce herself as Dr.
pharmaphorum
MAY 6, 2025
Eli Lilly has added another candidate to a growing pipeline of therapies for ALS, tapping Alchemab for an antibody sourced from 'resilient' patients
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MAY 6, 2025
NEW ORLEANSIn the face of economic uncertainty, health system executives and venture capitalists are setting a high bar for digital health and artificial intelligence investments.
pharmaphorum
MAY 6, 2025
A potentially pivotal trial PTC Therapeutics' therapy for Huntington's disease met its primary endpoint, but there are questions about the data
PharmExec
MAY 6, 2025
Blake Powers, CEO, medigi, explains how digital tools, AI, and automation are streamlining access to biosimilars and cell and gene therapies, signaling a shift toward more tech-enabled, patient-centric care.
pharmaphorum
MAY 6, 2025
The EU has announced a 500m to convince top scientific talent from around the world to relocate to Europe's "free and open" research environment
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
MAY 6, 2025
Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To rise to these challenges, the biopharma industry continues to develop innovative strategies to bring vital therapies swiftly to rare disease patients.
Pharma Marketing Network
MAY 6, 2025
The pharma industry is undergoing a seismic transformation. As 2025 unfolds, traditional business models are giving way to data-driven innovation, personalized care, and integrated digital ecosystems. Stakeholders across the healthcare spectrum must not only adapt to changethey must anticipate it. Imagine steering a ship through unpredictable currents.
Pharmaceutical Technology
MAY 6, 2025
Recursion Pharmaceuticals has narrowed its drug development pipeline as it seeks to reduce costs and reprioritise resources.
pharmaphorum
MAY 6, 2025
Incorporating NGS technology early in the drug development process lays the foundation for CDx development, and taking a co-development approach helps ensure patients have access to emerging therapies as soon as they are approved, positively impacting cancer patient outcomes while minimising the risks from inappropriate treatment.
Pharmacy Times
MAY 6, 2025
The agent targets B7-H3, a commonly overexpressed protein in diffuse intrinsic pontine glioma (DIPG).
Pharmaceutical Commerce
MAY 6, 2025
Blake Powers, CEO, medigi, explains how digital tools, AI, and automation are streamlining access to biosimilars and cell and gene therapies, signaling a shift toward more tech-enabled, patient-centric care.
PharmExec
MAY 6, 2025
Fran Gregory, VP, emerging therapies, Cardinal Health, emphasizes the need for long-term outcomes tracking and robust health economic modeling to demonstrate the sustained value of advanced therapies and support future payment strategies.
pharmaphorum
MAY 6, 2025
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR the leading professional society for HEOR globally about the ins and outs and trends of HEOR.
PharmExec
MAY 6, 2025
Rob Truckenmiller, CEO of PharmaCord, talks about the companys role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.
Pharmaceutical Commerce
MAY 6, 2025
As the adoption of biologics rises, demand for home healthcare grows, and conditions like diabetes and autoimmune disorders become more prevalent, self-injectables are here to stay.
PharmExec
MAY 6, 2025
Under terms of the deal, Alchemab will lead early Phase I trials for ATLX-1282 in amyotrophic lateral sclerosis, while Lilly will assume responsibility for further development and commercialization of the novel platform.
Pharmaceutical Technology
MAY 6, 2025
Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in the first quarter (Q1) of 2025 from $18.8bn in Q4 2024 to $37.7bn, according to leading data and analytics company GlobalDatas Pharmaceutical Intelligence Center Deals Database.
Pharma Tutor
MAY 6, 2025
Drug-Drug interactions : keep it up with challenges admin Tue, 05/06/2025 - 16:08 Drug-Drug interactions are identified through a combination of clinical observation, scientific research, pharmacological knowledge, and the use of specialized tools. In clinical practice, healthcare providers assess the risk of interactions by reviewing a patients complete medication list, including prescription drugs, over-the-counter products, and supplements.
Pharmaceutical Commerce
MAY 6, 2025
Fran Gregory, VP, emerging therapies, Cardinal Health, emphasizes the need for long-term outcomes tracking and robust health economic modeling to demonstrate the sustained value of advanced therapies and support future payment strategies.
PharmExec
MAY 6, 2025
The Refusal to File letter comes despite the FDAs prior encouragement to submit a supplemental biologics license application for Anktiva in patients with BCG-unresponsive non-muscle invasive bladder cancer with papillary disease.
Let's personalize your content